Bellini, Anna
Curti, Davide Gusmeo
Cursi, Marco http://orcid.org/0000-0002-7928-0417
Cecchetti, Giordano http://orcid.org/0000-0002-6544-410X
Agosta, Federica http://orcid.org/0000-0003-3121-4979
Fanelli, Giovanna F.
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 3 April 2024
Revised: 20 May 2024
Accepted: 22 May 2024
First Online: 31 May 2024
Declarations
:
: A. Bellini has received speaker honoraria from Angelini Pharma. G. Cecchetti has received speaker honoraria from Neopharmed Gentili. F. Agosta is Associate Editor of <i>NeuroImage: Clinical</i>, has received speaker honoraria from Biogen Idec, Italfarmaco, Roche, Zambon and Eli Lilly, and receives or has received research supports from the Italian Ministry of Health, the Italian Ministry of University and Research, AriSLA (Fondazione Italiana di Ricerca per la SLA), the European Research Council, the EU Joint Programme—Neurodegenerative Disease Research (JPND), and Foundation Research on Alzheimer Disease (France). M. Filippi is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, <i>Neurological Sciences,</i> and <i>Radiology</i>; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. Other authors have nothing to disclose.
: Local ethical standards committee on human experimentation approved the study protocol, which has been performed in accordance with the ethical standards of the 1964 Declaration of Helsinki. Moreover, all participants provided written informed consent prior to study inclusion.